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NMDANeuronal activity and energy metabolism are tightly coupled processes. Previously, we found that nuclear
respiratory factor 1 (NRF-1) transcriptionally co-regulates energy metabolism and neuronal activity by
regulating all 13 subunits of the critical energy generating enzyme, cytochrome c oxidase (COX), as well as
N-methyl-D-aspartate (NMDA) receptor subunits 1 and 2B, GluN1 (Grin1) and GluN2B (Grin2b). We also
found that another transcription factor, nuclear respiratory factor 2 (NRF-2 or GA-binding protein) regulates
all subunits of COX as well. The goal of the present study was to test our hypothesis that NRF-2 also regulates
speciﬁc subunits of NMDA receptors, and that it functions with NRF-1 via one of three mechanisms: comple-
mentary, concurrent and parallel, or a combination of complementary and concurrent/parallel. By means of
multiple approaches, including in silico analysis, electrophoretic mobility shift and supershift assays, in vivo
chromatin immunoprecipitation of mouse neuroblastoma cells and rat visual cortical tissue, promoter muta-
tions, real-time quantitative PCR, and western blot analysis, NRF-2 was found to functionally regulate Grin1
and Grin2b genes, but not any other NMDA subunit genes. Grin1 and Grin2b transcripts were up-regulated
by depolarizing KCl, but silencing of NRF-2 prevented this up-regulation. On the other hand, over-
expression of NRF-2 rescued the down-regulation of these subunits by the impulse blocker TTX. NRF-2 bind-
ing sites on Grin1 and Grin2b are conserved among species. Our data indicate that NRF-2 and NRF-1 operate in
a concurrent and parallel manner in mediating the tight coupling between energy metabolism and neuronal
activity at the molecular level.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Glutamate is the main excitatory neurotransmitter in the brain
and N-methyl-D-aspartate (NMDA) receptors are a major type of
glutamatergic receptors. NMDA receptors are ligand-gated, voltage-
dependent ionotropic receptors (for a review see [1]). They are
heterotetrameric proteins composed of the ubiquitous GluN1 subunit
in various combinations with the GluN2A-D and GluN3A-B subunits
[2–4]. While the NMDA receptors are crucial for the proper functioning
and activity of neurons, the properties of the receptors are dictated by
their subunit composition. Most NMDA receptors are composed of
two GluN1 subunits with two GluN2A or GluN2B subunits [2,5].
GluN1/GluN2A receptors are fast-acting and widely expressed in the
adult brain, while the GluN1/GluN2B receptors are slower acting but
widely expressed in the neonatal and the adult brain [3]. The GluN2C,or 2/GA binding protein; Grin,
+1 414 955 6517.
).
l rights reserved.GluN2D, GluN3A, and GluN3B receptor subunits aremore developmen-
tally and regionally expressed [4,6].
Our laboratory has recently shown that GluN1 and GluN2B receptor
subunits are regulated at the transcriptional level by nuclear respiratory
factor 1 (NRF-1) [7], which also regulates all 13 subunits of cytochrome
c oxidase (COX) [8], an enzyme critical for energy production in neu-
rons (for a review see [9]). Perturbations of neuronal activity result in
concurrent changes in mRNA and protein levels of COX subunits as
well as those of GluN1 (Grin1) andGluN2B (Grin2b) subunits [7,8]. Like-
wise, altering the expression of NRF-1 leads to parallel changes in COX,
GluN1, and GluN2B mRNA and protein expression [7,8]. Thus NRF-1
co-regulatesmediators of synaptic transmission and energy generation,
thereby coupling neuronal activity to energy metabolism.
Nuclear respiratory factor 2 (NRF-2), or GA binding protein (GAPB),
is a transcription factor in the E-26 transformation-speciﬁc (ETS) family
(for a review see [10]). The functional protein is composed of α and β
subunits that form either a heterodimer or a heterotetramer (α2β2)
[10]. The α subunit contains the ETS DNA binding domain that binds
to the ‘GGAA’ or ‘TTCC’ motif, and the β subunit contains the transcrip-
tional activation domain [10]. NRF-2 is involved in the control of basic
cellular processes, such as cell cycle progression, protein synthesis,
Table 1A
EMSA probes. Positions of probes are given relative to TSP. Putative NRF-2 binding sites
are underlined.
Gene
promoter
Position EMSA sequence
Grin1 −565/
−545
F: 5′ TTTTCTGGGGGAAGGATATTGGTGATTTCCTTCT 3′
R: 5′ TTTTAGAAGGAAATCACCAATATCCTTCCCCCAG 3′
Grin2a −334/
−319
F: 5′ TTTTAAATTTGGGGAATCTTGTGTGGAATTTGGA 3′
R: 5′ TTTTTCCAAATTCCACACAAGATTCCCCAAATTT 3′
Grin2b −159/
−133
F: 5′ TTTTAGCTTTTCCCACCCCCTGGCTACCCCACTTCCCCCA 3′
R: 5′ TTTTTGGGGGAAGTGGGGTAGCCAGGGGGTGGGAAAAGCT 3′
Grin2c −385/
−368
F: 5′ TTTTTATCTGGAAGCTTGAAAGTGGAAAGGCA 3′
R: 5′ TTTTTGCCTTTCCACTTTCAAGCTTCCAGATA 3′
Grin2d −330/
−314
F: 5′ TTTTTGGGTTCCATCTTTCCCTTCCACTC 3′
R: 5′ TTTTGAGTGGAAGGGAAAGATGGAACCCA 3′
Grin3a −598/
−587
F: 5′ TTTTGAAAAAGGAAGAGAGGAAGTAGAA 3′
R: 5′ TTTTTTCTACTTCCTCTCTTCCTTTTTC 3′
Grin3b −183/
−180
F: 5′ TTTTAGTGTACTTTTCCCCCAACAAA 3′
R: 5′ TTTTTTTGTTGGGGGAAAAGTACACT 3′
COX6b −47/
−23
F: 5′ TTTTTCCTCTTGCAGCTTCCGGCCAGTC 3′
R: 5′ TTTTGACTGGCCGGAAGCTGCAAGAGGA 3′
Table 1B
Mutant EMSA probes. Positions of probes are given relative to TSP. Mutated NRF-2
binding sites are underlined.
Gene
promoter
Position Sequence
Grin1 −565/
−545
F: 5′ TTTTCTGGGTTTTGGATATTGGTGATAAAATTCT 3′
R: 5′ TTTTAGAATTTTATCACCAATATCCAAAACCCAG 3′
Grin2b −159/
−133
F: 5′ TTTTAGCTTAAAACACCCCCTGGCTACCCCACAAAACCCA 3′
R: 5′ TTTTTGGGTTTTGTGGGGTAGCCAGGGGGTGTTTTAAGCT 3′
Grin3a −598/
−587
F: 5′ TTTTGAAAAATTTTGAGATTTTGTAGAA 3′
R: 5′ TTTTTTCTACAAAATCTCAAAATTTTTC 3′
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with neuronal activity regulating transcription and nuclear transloca-
tion of both its subunits [14–16]. NRF-2 and COX co-exist at the immu-
nohistochemical level, and physiological perturbations of neuronal
activity result in parallel changes in NRF-2 and COX protein expres-
sion [17,18]. Our lab has recently discovered that NRF-2, likeNRF-1, tran-
scriptionally regulates all subunit genes of the COX enzyme [19–21]. The
question naturally arises as to whether NRF-2 also couples energy
metabolism to neuronal activity by regulating speciﬁc subunits of the
NMDA receptors. If so, do the two transcription factors operate via com-
plementary, concurrent and parallel, or a combined complementary and
concurrent/parallel mechanism? The goal of the present study was to
test our hypothesis that NRF-2 also mediates the coupling of synaptic
transmission and energy metabolism.
2. Material and methods
All experiments were carried out in accordance with the US Na-
tional Institutes of Health Guide for the care and use of laboratory an-
imals and the Medical College of Wisconsin regulations. All efforts
were made to minimize the number of animals and their suffering.
2.1. Cell culture
Murine neuroblastoma (N2a) cells (ATCC, Manassas, VA, USA)
were grown in Dulbecco's modiﬁed Eagle's medium supplemented
with 10% fetal bovine serum, 50 units/mL penicillin, and 100 μg/mL
streptomycin (Invitrogen, Carlsbad, CA, USA) at 37 °C in a humidiﬁed
atmosphere with 5% CO2.
2.2. In silico analysis of promoters of murine NMDA receptor subunit
genes
DNA sequences surrounding the transcription start points (TSPs) of
N-methyl-D-aspartate (NMDA) receptor subunit genes (Grin1,Grin2a-d,
Grin3a-b) were derived from the NCBI mouse genome database (Grin1
GenBank ID: NC_000068.7, Grin2a GenBank ID: NC_000082.6, Grin2b
GenBank ID: NC_000072.6, Grin2c GenBank ID: NC_000077.6, Grin2d
GenBank ID: NC_000073.6, Grin3a GenBank ID: NC_000070.6, and
Grin3b GenBank ID: NC_000076.6). These promoter sequences
encompassed 1 kb upstream and 1 kb downstream of the TSP of
each gene analyzed. Computer-assisted search for NRF-2's binding
motif ‘GGAA’, or its complement ‘TTCC’, separated by up to 24 base
pairs (bp) from another such NRF-2 binding motif, was conducted on
each promoter.
Alignment of human, mouse, and rat promoter sequences was
performed with NCBI's Ensembl interface. Mouse NMDA receptor
promoter sequences were compared with those of rat and human ge-
nomic sequences for conservation of the NRF-2 binding motif.
2.3. Electrophoretic mobility shift and supershift assays
Electrophoretic mobility shift assays (EMSA) for possible NRF-2
interactions with putative binding elements on all NMDA receptor
subunit promoters were carried out with a few modiﬁcations from
methods previously described [21]. Brieﬂy, based on in silico analysis,
oligonucleotide probes with a putative NRF-2 binding motif in a
tandem repeat on each NMDA receptor subunit promoter were syn-
thesized (Table 1A), annealed, and labeled by a Klenow fragment
(Invitrogen, Grand Island, NY, USA) ﬁll-in reaction with [α-32P] dATP
(50 μCi/200 ng; Perkin-Elmer, Shelton, CT, USA). N2a nuclear extract
was isolated using methods described previously [22]. Each labeled
EMSA probe was incubated with 2 μg of calf thymus DNA and 15 μg of
N2a nuclear extract. The probe reaction was processed for EMSA.
Supershift assays were performedwith 0.4 μg of NRF-2 speciﬁc antibody
(polyclonal rabbit antibody, H-180, sc-22810, Santa Cruz Biotechnology,Santa Cruz, CA, USA) added to the probe/nuclear extract mixture and
incubated for 20 min at 24 °C. For competition, 100-fold excess of
unlabeled oligonucleotides was incubated with nuclear extract before
the addition of labeled oligonucleotides. Shift reactions were loaded
onto 4.5% polyacrylamide gel (58:1, Acrylamide:Bisacrylamide) and
run at 200 V for 4.2 h in 0.25× Tris-borate-EDTA buffer. Results were vi-
sualized by autoradiography and exposed on ﬁlm. Rat cytochrome c ox-
idase subunit 6b (COX6b) with known NRF-2 binding site was designed
as previously described [21] and used as a positive control. NRF-2 mu-
tants with mutated sequences, as shown in Table 1B, were used as neg-
ative controls.
2.4. Chromatin immunoprecipitation (ChIP) assays in N2a cells
ChIP assays were performed similar to those described previously
[7]. Brieﬂy, 1×106 N2a cells were used for each immunoprecipitation
reaction. Cells were ﬁxed with 1% formaldehyde for 10 min at 24 °C.
Following formaldehyde ﬁxation, cells were resuspended in swelling
buffer (5 mM PIPES, pH 8.0, 85 mM KCl, and 1% Nonidet P-40
(Sigma, St Louis, MO, USA), with protease inhibitors added right be-
fore use) and homogenized 10 times in a small pestle Dounce tissue
homogenizer (5 mL). Nuclei were then isolated by centrifugation
before being subjected to sonication in SDS lysis buffer (1% SDS,
10 mM EDTA, 50 mM Tris–HCl, pH 8.1 (Sigma)). The sonicated ly-
sate was immunoprecipitated with either 1 μg of NRF-2 polyclonal
rabbit antibody (H-180, Santa Cruz Biotechnology) or 2 μg of anti-
nerve growth factor receptor (NGFR) p75 polyclonal goat antibody
(C20, sc-6188, Santa Cruz Biotechnology). Semi-quantitative PCR
was performed using 1/20th of precipitated chromatin. Primers
encompassing putative NRF-2 tandem repeats near TSPs of NMDA
receptor subunit genes (identiﬁed in in silico analysis) were designed
(Table 2) as previously described [8]. COX6b promoterwithNRF-2 bind-
ing site was used as a positive control, and exon 8 of NRF-1, a region of
DNA that does not contain a NRF-2 binding site, was used as a negative
Table 2
Primers and conditions used for ChIP analysis.
Gene
promoter
Position of
PCR
product
Sequence Cycling
conditions
Grin1 −642/
−418
F: 5′ GCCTTGAACTCTAGCAATCCT 3′ 94°: 30 s, 57°: 30 s,
72°: 45 s.R: 5′ GGAGGGAATGCATTGTGAAT 3′
Grin2a −467/
−257
F: 5′ TCGATAACTTGGTCCACGCACTTG 3′ 94°: 30 s, 57°: 30 s,
72°: 45 s.R: 5′ TGGCATCCTCCTTCCTTCTCTCTT 3′
Grin2b −324/
−91
F: 5′ GGAGTGGTTTCAGTGTCAGTCTGC 3′ 94°: 30 s, 57°: 30 s,
72°: 45 s.R: 5′ TAAGACTCTTGGCTGAGGCTGCTT 3′
Grin2c −471/
−248
F: 5′ AAAAGAAGGTCCCCCAGTGT 3′ 94°: 30 s, 57°: 30 s,
72°: 45 s.R: 5′ TTGGGCCAGTTAATTTCGAG 3′
Grin2d −388/
−151
F: 5′ TCCTGGTTCCCACATTTCAT 3′ 94°: 30 s, 57°: 30 s,
72°: 45 s.R: 5′ GGGAAAGTTGGGTGAGAGAA 3′
Grin3a −700/
−499
F: 5′ AACTTTGGCGCTCAGAACAGAACC 3′ 94°: 30 s, 57°: 30 s,
72°: 45 s.R: 5′ AGCTGCCGAACCTGCTTCCTTT 3′
Grin3b −251/
−50
F: 5′ ATCTGATCAGCAAGACCCACAGGA 3′ 94°: 30 s, 57°: 30 s,
72°: 45 s.R: 5′ TGAGGCAGGCACATCTGGTAGAAA3′
COX6b −187/
+44
F: 5′ AAAGTGCGCAGGCGCTGGAG 3′ 94°: 30 s, 57°: 30 s,
72°: 45 s.R: 5′ CCGAGACGCTGACAGCACCG 3′
Exon 8 of
NRF-1
F: 5′ GTGGAACAAAATTGGGCCAC 3′ 94°: 30 s, 57°:
30 s, 72°: 45 s.R: 5′ CTGTTAAGGGCCATGGTGA 3′
Table 3A
Primers used for promoter cloning analysis.
Gene
promoter
Position Primer
Grin1 −719/+483 F: 5′ CAGGGTACCTGTGGTGTTCCCCTCCCTCCA 3′
R: 5′ CAGAAGCTTCCCAGGCCTTTCCAGGGACCA 3′
Grin2b −878/+248 F: 5′ CAGACGCGTGCTCAAGAGGGAGAGAAATGGCTGC 3′
R: 5′ CAGCTCGAGGCGTTCGGCAGCAGGAGAGG 3′
COX6b −291/+44 F: 5′ TTGGTACCACTCTGCAGACAGCCTCAC
R: 5′ TTAAGCTTCGGAGCAGCGTTACTTCAAT
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merase (Thermo-Fisher Scientiﬁc, Waltham, MA, USA). Optimal use of
cycling parameters (Table 2) and PCR additives (betaine) signiﬁcantly
improved the quality and reproducibility of ChIP. PCR products were vi-
sualized on 2% agarose gels stained with ethidium bromide.
2.5. Chromatin immunoprecipitation (ChIP) assays from murine visual
cortical tissue
ChIP assays were performed on primary neurons similar to that
described for N2a cells above. Brieﬂy, 0.1 g of murine visual cortical
tissue was used for each immunoprecipitation reaction. From fresh
murine brain, the visual cortex was quickly dissected and cut into
small pieces. The ﬁnely chopped visual cortical tissue was ﬁxed with
2% formaldehyde for 20 min at 24 °C. Following formaldehyde ﬁxa-
tion, cells were resuspended in swelling buffer and homogenized as
described above. Nuclei isolation and immunoprecipitation, as well
as the analysis of immunoprecipitated samples, including primers
for positive and negative controls were identical to the ChIP protocol
described for N2a cells above.
2.6. Construction and transfection of luciferase reporter vectors for promoter
mutagenesis study
Luciferase reporter constructs of Grin1 and Grin2b gene promoters
were made by PCR cloning their proximal promoter sequences using
genomic DNA prepared frommouse N2a cells as a template. Digestion
with restriction enzymes KpnI and HindIII for Grin1 and MluI and
XhoI for Grin2b was performed, followed by ligation of the product
directionally into pGL3basic luciferase vector (E1751, Promega,Madison,
WI, USA). Sequences of primers used for PCR cloning are provided in
Table 3A. COX6b clone was used from our previous study as a positive
control [21]. Site-directed mutations of putative tandem repeat of
NRF-2 binding sites on eachpromoterwere generated using QuikChange
site-directed mutagenesis kit (Stratagene, La Jolla, CA, USA). Primers for
mutagenesis are listed in Table 3B. All constructs were veriﬁed by
sequencing.
Each promoter construct was transfected into N2a cells in a 24-well
plate using Lipofectamine 2000 (Invitrogen) and cell lysates harvested
after 48 h. Each well received 0.6 μg of reporter construct and 0.06 μg
of pRL-TK renilla luciferase vector (E2241, Promega), a vector with
thymidine kinase (TK) promoter that constitutively expressed renilla
luciferase. Transfected neurons were stimulated with KCl at a ﬁnal
concentration of 20 mM in the culture media for 5 h as previouslydescribed [7]. After 5 h of treatment, cell lysates were harvested and
measured for luciferase activity as described previously [7]. Data
from six independent transfections were averaged for each promot-
er construct.
2.7. Plasmid construction of NRF-2 shRNA, transfection, and KCl treatment
NRF-2 silencing was carried out using two small hairpin RNA
(shRNA) sequences against murine NRF-2α that were cloned into
the pBS/U6 parent vector. Target NRF-2α shRNA sequences were
5′-ATTGCCCAGCCAGTCACG-3′ and 5′-AGAAGACAGAAGTTCACCG-3′.
The pBS/U6 empty parent vector was used as the negative control.
The pLKO.1-puro-CMV-TurboGFP Positive Control Vector (SHC003,
Sigma) containing turboGFP and puromycin resistance was used to
visualize transfection efﬁciency and select for positively transfected
cells.
For transfection, N2a cells were plated at 60% conﬂuency in 6-well
dishes. Cells were co-transfected the day after plating with either the
NRF-2 shRNA construct (2 μg) and turboGFP (0.5 μg) vectors or the
pBS/U6 empty vector (2 μg) and the turboGFP (0.5 μg) vector using
5 μL of JetPrime transfection reagent (PolyPlus Transfection, Illkirch,
France) per well. Puromycin at a ﬁnal concentration of 5 μg/mL was
added to the culture medium 1.5 days after transfection to select for
purely transfected cells. Green ﬂuorescence was observed to monitor
transfection efﬁciency. Transfection efﬁciency for N2a cells was around
75%, however puromycin selection effectively yielded 100% transfected
cells. N2a cells transfectedwith shRNAagainst NRF-2were further stim-
ulated with KCl at a ﬁnal concentration of 20 mM in the culture media
for 5 h as previously described [7]. After 5 h of treatment, cells were
harvested for RNA isolation.
2.8. NRF-2 over-expression and TTX treatment
Vectors expressing human NRF-2α and NRF-2β subunits were
constructed by PCR cloning the human NRF-2α and NRF-2β from HeLa
cell cDNA and human skeletal muscle cDNA library, respectively, and
were described previously [19]. The primer pairs used to amplify
NRF-2α and NRF-2β (Table 4) had added HindIII/KpnI and NotI/BamHI
restriction sites to their products, respectively. Ampliﬁcation was done
with Taq polymerase and products were cloned into pGEMT-EZ using
TA cloning Kit (Promega). Clones were picked and sequenced to verify
correct DNA sequence for protein expression. The NRF-2α and NRF-2β
cDNAswere then subcloned directionally into pcDNA3.1 vector by dou-
ble restriction enzyme digest. The sequence of each plasmid construct
was veriﬁed by sequencing.
For transfection, N2a cells were plated at 60% conﬂuency in 6-well
dishes. Cells were transfected the day after plating with either the
NRF-2 over-expression construct (2 μg) vector, or the pcDNA3.1 empty
(1.5 μg) and turboGFP (0.5 μg) vectors, using 5 μL of JetPrime transfec-
tion reagent per well. Green ﬂuorescence was used to monitor transfec-
tion efﬁciency. Transfected N2a cells were impulse blocked for 3 days
with TTX at a ﬁnal concentration of 0.4 μM, starting the day after plating
as previously described [7]. Four days after transfection, cells were
harvested for RNA isolation.
Table 3B
Primers used for promoter mutagenesis analysis. Mutated NRF-2 binding sites are underlined.
Gene promoter Position Primer
Mut. NRF-2 Grin1 −576/−529 F: 5′ CCCTATCAGAATGCAATCACCAATATCCTGCACCCAGCGGTATAGAGG 3′
R: 5′ CCTCTATACCGCTGGGTGCAGGATATTGGTGATTGCATTCTGATAGGG 3′
Mut NRF-2 Grin2b −170/−122 F: 5′ GGGTTAAGCTTTGTCCACCCCCTGGCTACCCCACTGCCCCCAGCTCATG 3′
R: 5′ CATGAGCTGGGGGCAGTGGGGTAGCCAGGGGGTGGACAAAGCTTAACCC 3′
Mut NRF-2 COX6b −35/−32 F: 5′ TCTCCTCTTGCAGCTAGAGGCCAGTCGGAATTCCG 3′
R: 5′ CGGAATTCCGACTGGCCTCTAGCTGCAAGAGGAGA 3′
51A. Priya et al. / Biochimica et Biophysica Acta 1833 (2013) 48–582.9. RNA isolation and cDNA synthesis
Total RNA was isolated using TRIZOL (Invitrogen) according to the
manufacturer's instructions. 1 μg of total RNA was treated with DNase I
and the reaction stopped with heating at 65 °C in the presence of EDTA.
cDNA was synthesized using iScript cDNA synthesis kit (170-8891,
BioRad, Hercules, CA, USA) according to the manufacturer's instructions.2.10. Real-time quantitative PCR
Real-time quantitative PCRwas carried out in a Cepheid Smart Cycler
Detection system (Cepheid, Sunnyvale, CA, USA) and/or the iCycler Sys-
tem (BioRad) using the IQ Sybr Green SuperMix (170-8880, BioRad)
following the manufacturer's protocols and as described previously [7].
The primer sequences used are shown in Table 5. Primers were opti-
mized to yield 95%–105% reaction efﬁciency with PCR products run on
agarose gel to verify the correct ampliﬁcation length.Melt curve analyses
veriﬁed the formation of single desired PCR product in each PCR reaction.
COX7c real time primerwas used as a positive control. Gapdh and β-actin
real-time primers were used as internal controls for silencing and over-
expression experiments, respectively. The 2-ΔΔCT method was used to
quantify the relative amount of transcripts [23].Table 5
Real time primers.
Gene Primer
Grin1 F: 5′ CGGCTCTTGGAAGATACAG 3′
R: 5′ GAGTGAAGTGGTCGTTGG 3′
Grin2a F: 5′ TAGACCTTAGCAGGCCCTCTC 3′
R: 5′ GAGCTTTTGTTCCCCAAGAGT 3′
Grin2b F: 5′ TCATGGTGTCAGTGTGGGCCTTCT 3′
R: 5′ TTCTTGTCACTCAGGCCGGAAACC 3′
Grin2c F: 5′ GTTGTAAGGGCTTCTGCATCGACAT 3′
R: 5′ CGATCATACCATTCCACACACCACG 3′
Grin2d F: 5′ TCAATGAGGATGGCTTTCTGG 3′
R: 5′ CATAGAGGGTACTTGAGGCG 3′
Grin3a F: 5′ GGGAAGGATTGTCATGGACTCGGG 3′
R: 5′ AGCAGGGCATAAGCCTTCATCATCT 3′2.11. Western blot analysis
Control, NRF-2 shRNA and over-expression samples were harvested
in RIPA buffer (150 mM sodium chloride, 1.0% NP-40, 0.5% sodium
deoxycholate, 0.1% sodium dodecyl sulfate, 50 mM Tris, pH 8.0) with a
protease inhibitor cocktail (Protease Inhibitor Cocktail III, Research Prod-
ucts International Corp. (RPI),Mount Prospect, IL, USA) added just before
use. Samples were loaded onto 10% SDS-PAGE gel and protein was elec-
trophoretically transferred onto polyvinylidene diﬂuoride membranes
(Bio-Rad). Subsequent to blocking, blots were incubated in primary anti-
bodies against NRF-2α (H-180, 1:1000, Santa Cruz Biotechnology),
NRF-2β (gift of Dr. Richard Scarpulla), GluN1 (1:1000; Millipore
Chemicon, Billerica, MA, USA), GluN2A (1:5000; PhosphoSolutions,
Aurora, CO, USA), and GluN2B (1:1000; PhosphoSolutions). β-Actin
(1:3000; Sigma) served as loading control. Secondary antibodies used
were goat-anti-rabbit and goat-anti-mouse antibodies (Vector Labora-
tories, Burlingame, CA, USA). Blots were then reacted with ECL reagent
(Pierce, Rockford, IL, USA) and exposed to autoradiographic ﬁlm (RPI).
Quantitative analyses of relative changes were done with an Alpha
Imager (Alpha Innotech, San Leandro, CA, USA).Table 4
NRF-2α and NRF-2β cloning primers.
Gene Primer
NRF-2α F: 5′ AAGCTTACTCCAGCCATGACTAAAAG3′
R: 5′ GGTACCAGCTATACTTGCTCTAAACAT3′
NRF-2β F: 5′ TTGCGGCCGCGATGTCCCTGGTAGATTTG 3′
R: 5′ AAGGATCCTTAAACAGCTTCTTTATTAGTC 3′2.12. Statistical analysis
Signiﬁcance among groupmeanswas determined by analysis of var-
iance (ANOVA). Signiﬁcance between two groups was analyzed by
Student's t-test. P-values of 0.05 or less were considered signiﬁcant.
3. Results
3.1. In silico promoter analysis of NMDA receptor subunit genes
In silico analysis of the proximal promoters of murine NMDA re-
ceptor subunit genes, speciﬁcally the DNA sequence 1 kb upstream
and 1 kb downstream of TSP, revealed the NRF-2 binding motif, ‘GGAA’,
or its complement, ‘TTCC’, in a tandem repeat (separated by up to
24 bp) in all NMDA receptor subunit gene promoters except for Grin3b
(see Table 1A for the binding motif of NRF-2).
3.2. In vitro binding of NRF-2 to NMDA receptor subunit promoters
The electrophoretic mobility shift assays (EMSA) and supershift as-
says were performed to determine NRF-2's ability to bind its candidate
site in vitro. As the promoter of Grin3b did not contain a NRF-2 tandem
repeat, an oligonucleotide probe encompassing the single conserved
NRF-2 binding site was used. Murine cytochrome c oxidase subunit
6b (COX6b) promoter, with a known NRF-2 binding site at position
−47/−23 bp upstream of the TSP, served as the positive control.
When incubated with N2a nuclear extract, COX6b formed speciﬁc
DNA/NRF-2 shift and supershift complexes (Fig. 1A, lanes 1 and 3, re-
spectively). When an excess of unlabeled COX6b probe was added as aGrin3b F: 5′ GGCTGCACACCAGTCAGAGGTT 3′
R: 5′ GAGCTGCTGGGGTCCCATGT 3′
COX7c F: 5′ ATGTTGGGCCAGAGTATCCG 3′
R: 5′ ACCCAGATCCAAAGTACACGG 3′
NRF2-α F: 5′ CTCCCGCTACACCGACTAC 3′
R: 5′ TCTGACCATTGTTTCCTGTTCTG 3′
NRF2-β F: 5′ ACCAACCAGTGGGATGGGTCAG 3′
R: 5′ GCACATTCCACCCGGCTCTCAAT 3′
Actb F: 5′ GTGACGTTGACATCCGTAAAGA 3′
R: 5′ GCCGGACTCATCGTACTCC 3′
Gapdh F: 5′ AGGTCGGTGTGAACGGATTTG 3′
R: 5′ GGGGTCGTTGATGGCAACA 3′
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tor subunit gene promoters, only Grin1, Grin2b, and Grin3a probes gave
positive shift and NRF-2 supershift bands. Speciﬁcally, shift bands
for Grin1, Grin2b, and Grin3a were observed (Fig. 1A, lanes 4 and
9, Fig, 1B, lane 1, respectively) but were absent for Grin2a, Grin2c,
Grin2d, and Grin3b (Fig. 1B, lanes 9–12). Shift bands for Grin1,
Grin2b, and Grin3a were competed out by cold competitors (Fig. 1A,
lanes 5 and 10, Fig. 1B, lane 2, respectively). Supershift bands with
NRF-2 antibody were present for Grin1, Grin2b, and Grin3a (Fig. 1A,Fig. 1. In vitro binding activity of NRF-2 to putative binding sites on NMDA receptor subun
nucleotides, excess unlabeled oligos as competitors, excess unlabeled mutant NRF-2 oligo
a− sign. Arrowheads indicate speciﬁc NRF-2 shift, supershift, and non-speciﬁc complexes.
band. When excess unlabeled competitor was added, it did not yield a band (A, lane 2).
shift and supershift bands that were competed out by excess unlabeled competitors (A, lan
Grin2b were not competed out by an excess of unlabeled mutant NRF-2 oligos (A, lanes 7 an
ative controls, and they did not yield speciﬁc bands (A, lanes 17–19; A, lanes 14–16, respectivel
result in a shift band for Grin1 orGrin2b (A, lanes 8 and 13, respectively). (B) Grin3a promoter c
competed out by an excess of unlabeled competitors (B, lanes 1, 3, and 2, respectively). An exc
NRF-2 oligos did not yield speciﬁc shift or supershift bands (B, lanes 6–8). Labeled Grin3a oligo
Grin2d, and Grin3b oligos did not yield speciﬁc shift bands (B, lanes 9–12, respectively).lanes 6 and 11, Fig. 1B, lane 3, respectively). An excess of unlabeled
Grin1, Grin2b, and Grin3a probes with mutated NRF-2 binding sites
was added to respective radiolabeled probes, and they did not compete
out the respective shift reactions (Fig. 1A, lanes 7 and 12, Fig. 1B, lane 4,
respectively). Labeled Grin1, Grin2b, and Grin3a probes were also incu-
bated with NRF-2 antibody without N2a nuclear extract to serve as a
control for antibody-to-oligo interaction, and they did not yield any
shift or supershift bands (Fig. 1A, lanes 8 and 13, Fig. 1B, lane 5, respec-
tively). Shift, competitor, and supershift reactions with mutated Grin1,it promoters as determined with EMSA and supershift assays. (A–B) 32P-labeled oligo-
s as competitors, N2a nuclear extract, and NRF-2α antibodies are indicated by a+ or
(A) The positive control, Cox6b, shows a shift (A, lane 1) and a supershift (A, lane 3)
Grin1 and Grin2b promoters containing putative NRF-2 binding sites showed speciﬁc
es 4, 6, and 5; lanes 9, 11, and 10, respectively). The speciﬁc shift bands for Grin1 and
d 12, respectively). Labeled mutated NRF-2 sites on Grin1 and Grin2b were used as neg-
y). Using labeled probe and NRF2α antibody alone in the absence of nuclear extract did not
ontaining putative NRF-2 binding site showed speciﬁc shift and supershift bands that were
ess of unlabeled mutant NRF-2 oligos was not able to compete (B, lane 4). Labeled mutant
with NRF-2α antibody alone did not result in any band (B, lane 5). Labeled Grin2a, Grin2c,
Fig. 2. In vivo ChIP assays for NRF-2 interaction with NMDA receptor subunits in N2a cells
(A) andmurine visual cortical neurons (B). Chromatinwas precipitatedwith anti NRF-2α
antibodies (NRF-2 IP lane), anti-nerve growth factor receptor p75 antibody (negative con-
trol, NGFR IP lane) or no antibody (negative control, no Ab lane). Control reactions for PCR
were performedwith 0.5% (input 0.5% IP lane) and 0.1% (input 0.1% IP lane) of input chro-
matin. Cox6B promoter was used as a positive control, and Exon 8 of NRF-1 was used as a
negative control. Results indicate interactions of NRF-2withGrin1 andGrin2b but notwith
Grin2a,Grin2c, Grin2d,Grin3a, orGrin3b in bothN2a cells andmurine visual cortical tissue.
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14–19, Fig. 1B, lanes 6–8, respectively).
3.3. In vivo interaction of NRF-2 with NMDA receptor subunit genes in
N2a Cells
The chromatin immunoprecipitation (ChIP) assaywas performed to
verify NRF-2 protein interactionwith NMDA receptor subunit gene pro-
moters in vivo in N2a cells. Sonicated nuclear lysates from N2a cells
were immunoprecipitated with NRF-2 antibody and the resulting DNA
was subjected to PCR analysis using primers that encompassed the
putative NRF-2 binding site identiﬁed by in silico analysis. As a control
for the immunoprecipitation reaction, nerve growth factor receptor
(NGFR) antibody was used. As an additional control to eliminate the
possibility of a bead-to-DNA interaction, a “no antibody” control was
used. As NRF-2 is known to regulate COX6b [21], primers against the
COX6b gene promoter were used as a positive control for the immuno-
precipitation, whereas exon 8 of NRF-1, a region of DNA that does not
contain a NRF-2 binding site, was used as a negative control. As a posi-
tive control for the PCR reaction, 0.5% and 0.1% input DNA were used.
Determination of NRF-2 binding to promoter regions was done by par-
allel PCR ampliﬁcation of all controls and the immunoprecipitated
samples.
As seen in Fig. 2A, agarose gel analysis of PCR products revealed
speciﬁc bands for input controls in all the tested regions of the prox-
imal NMDA receptor subunit gene promoters. Furthermore, the NRF-2
immunoprecipitated sample revealed an enriched band for COX6b pos-
itive control and for Grin1 and Grin2b, but not for exon 8 of NRF-1 neg-
ative control. An enriched band did not occur in the NGRF or “no
antibody” negative controls. There was also no enrichment of DNA in
the NRF-2 immunoprecipitated samples for Grin2a, Grin2c, Grin2d,
Grin3a, and Grin3b.
3.4. In vivo interaction of NRF-2 with NMDA receptor subunit genes in
murine visual cortex
To rule out the possibility that the ChIP data, especially the negative
result for Grin3a, was not exclusive for N2a cells, ChIP assays were also
performed with sonicated nuclear extract from visual cortical tissue of
wild type C6BL/J6 mice. The nuclear extract was immunoprecipitated
with NRF-2 antibody. Immunoprecipitations with NGFR antibody and
a “no antibody” reaction were used as negative controls. Positive and
negative controls for PCR analysis of immunoprecipitated products
were similar to those of ChIP assays performed with N2a cell nuclear
lysate described above.
As seen in Fig. 2B, agarose gel analysis of PCR products of the input
control revealed speciﬁc bands in all the tested regions of the proximal
NMDA receptor subunit gene promoters. NRF-2 immunoprecipitated
samples revealed an enriched band for the COX6b positive control and
for Grin1 and Grin2b gene promoters, but not for exon 8 of NRF-1 nega-
tive control. Therewas no enriched band in theNGRF and “no antibody”
negative controls. Likewise, no enriched bands were found for Grin2a,
Grin2c, Grin2d, Grin3a, and Grin3b in the NRF-2 immunoprecipitated
samples.
3.5. Effect of mutated NRF-2 binding sites on Grin1, Grin2b, and COX6b
promoters
Promoters of NMDA receptor subunit genes that were identiﬁed
by in silico analysis to contain NRF-2 binding sites and found to bind
to NRF-2 in vitro and in vivowere cloned into the pGL3 basic luciferase
vector. Site-directed mutations of the putative NRF-2 binding sites on
these NMDA receptor subunit gene promoters identiﬁed by speciﬁc
EMSA shift and supershift reactions were constructed. Transfection of
control promoter regions or mutated NRF-2 binding regions into N2a
cells revealed a signiﬁcant 26% decrease in the promoter activity ofthe Grin1 promoter containing the mutated NRF-2 motif, and a signiﬁ-
cant 41% decrease in that of the mutated Grin2b promoter as compared
to controls (Pb0.001 for all, Fig. 3). The COX6b promoter was used as a
positive control. The COX6b promoter containing a mutated NRF-2
motif showed a signiﬁcant decrease in the promoter activity (Pb0.001,
Fig. 3).
3.6. Effect of mutated NRF-2 binding sites on the response of Grin1 and
Grin2b promoters to KCl stimulation
To verify that NRF-2 binding is necessary for the up-regulation of
Grin1 and Grin2b transcripts by KCl stimulation, Grin1 and Grin2b pro-
moters with or without mutated NRF-2 binding sites were cloned into
the pGL3 basic vectors and transfected into N2a cells. As shown in
Fig. 3, N2a cells transfected with wild type Grin1 or Grin2b promoters
and subjected to KCl depolarizing stimulation showed a signiﬁcant in-
crease (143% and 144% for Grin1 and Grin2b, respectively) in promoter
expression, as monitored by luciferase assays (Pb0.001 for both). This
Fig. 3. Site-directed mutational analysis of promoters of wild type (wt) and those with
mutated NRF-2 binding site (mut) for Cox6b, Grin1, and Grin2b genes. Cox6b served as a
positive control, and mutating the NRF-2 site resulted in a signiﬁcant decrease in the
luciferase activity as compared to the wild type. Similarly, mutating the NRF-2 binding
sites on Grin1 and Grin2b genes resulted in signiﬁcant decreases in luciferase activity.
KCl depolarization signiﬁcantly increased promoter activity in all wild types, but not
in Cox6b, Grin1 and Grin2b promoters with mutated NRF-2 sites. N=6 for each con-
struct. ***=Pb0.001; X=NS. All mutants and wild type+KCl are compared to the
wild type. All mutant+KCl are compared to mutants.
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conﬁrming a requirement for NRF-2 binding in the KCl depolarization-
induced up-regulation of the Grin1 and Grin2b transcripts.Fig. 4. Effect of RNA interference-mediated silencing of NRF-2α on the expression of COX
NRF-2α, GluN1 and GluN2B, but not GluN2A, protein in shRNA-transfected N2a cells. β-Ac
scripts in N2a cells transfected with NRF-2α shRNA as compared to control vectors. Grin1
Grin2c, Grin2d, Grin3a, and Grin3b. As a positive control, COX7c mRNA levels were also de
and X=non-signiﬁcant when compared to controls.3.7. Effect of silencing NRF-2 by RNA interference
To determine the effect of silencingNRF-2α transcript on the expres-
sion of NMDA receptor subunits, plasmid vectors expressing small hair-
pin RNA (shRNA) against two target sequences of NRF-2αmRNA were
used. These vectorswere previously found to silenceNRF-2α expression
inN2a cells [19]. Analysis of cDNAs of N2a cells transfectedwithNRF-2α
shRNA vectors was done using quantitative real-time PCR and the
2-ΔΔCT method. Gapdh was used as the internal control, and silenced
NRF-2α samples were compared against the control vector samples. Si-
lencing of NRF-2α resulted in a 58% decrease in the levels of NRF-2α
mRNA, with a 39% decrease in the mRNA levels of the positive control,
COX7c (Pb0.001 for both, Fig. 4B). Protein levels of NRF2α decreased
signiﬁcantly by 52% (Pb0.001, Fig. 4A). mRNA levels of Grin1 and
Grin2b decreased signiﬁcantly by 38.5% and 45%, respectively (Pb0.001
and Pb0.01, respectively; Fig. 4B), with protein levels decreasing by
87% and 83%, respectively (Pb0.001 for both, Fig. 4A). mRNA levels of
the remaining NMDA receptor subunits were not signiﬁcantly changed
(Fig. 4B), and neither was the protein level of GluN2A (Fig. 4A).
3.8. Effect of over-expressing NRF-2
To determine the effect of over-expressing NRF-2 transcript on
the transcript levels of NMDA receptor subunits, plasmid over-
expression vectors containing human NRF-2α and human NRF-2β
were co-transfected into N2a cells. β-Actin was used as the internal
control. Over-expression of NRF-2α and β resulted in an approximatelyand NMDA receptor subunit genes. (A) Western blots revealed a down-regulation of
tin served as a loading control. (B) Real-time PCR revealed a down-regulation of tran-
and Grin2b mRNA levels decreased with NRF-2α silencing, but not those of Grin2a,
creased with NRF-2α silencing. N=6 for each data point; **=Pb0.01, ***=Pb0.001,
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spectively (Pb0.001 for both; Fig. 5B), and a 3.5-fold and 4.25-fold in-
crease in their protein levels, respectively (Pb0.001 for both; Fig. 5A).
As a positive control, over-expression resulted in a 145.5% increase in
COX7c transcript levels (Pb0.001, Fig. 5C). Over-expression of NRF-2
also resulted in a signiﬁcant increase of 158.6% and 221.7% in the
mRNA level of Grin1 and Grin2b, respectively (Pb0.001 for both;
Fig. 5C), with a signiﬁcant 422% and 376% increase (Pb0.001 for
both), respectively, in their protein levels (Fig. 5A). mRNA levels of
the remaining NMDA receptor subunits (Grin2a, Grin2c, Grin2d,
Grin3a, and Grin3b) did not change signiﬁcantly (Fig. 5C), neither
did the protein level of GluN2A (Fig. 5A).3.9. Silencing NRF-2 abolished KCl-induced transcript up-regulation of
Grin1 and Grin2b
Wehave previously shown that COX subunits are up-regulated in re-
sponse to KCl, and that this up-regulation is dependent on NRF-2 func-
tion. To determine the response of Grin1 and Grin2b mRNA to KCl after
NRF-2 silencing, N2a control cells and cells transfected with NRF-2α
shRNA were subjected to 20 mM KCl for 5 h. As seen in Fig. 6A,
depolarizing stimuli in control cells resulted in a 225% and 254% increase
in Grin1 and Grin2b transcript levels, respectively (Pb0.001 for both). In
the presence of NRF-2α shRNA, however, 20 mM KCl treatment for 5 h
failed to increase Grin1 and Grin2b transcript levels (Fig. 6A). Transcript
levels of COX7c positive control increased signiﬁcantly (145%, Pb0.01;
Fig. 6A) with KCl depolarization, but was abolished with shRNA treat-
ment. Transcript levels of Grin2a and Grin3a increased signiﬁcantly
with KCl treatment (Pb0.001 for both; Fig. 6A) that remained as such
in the presence of NRF-2α shRNA treatment (Fig. 6A).Fig. 5. Effect of NRF-2α and β over-expression on the transcript and protein levels of COX and
and NRF-2βwith NRF-2α/β over-expression. GluN1 and GluN2B, but not GluN2A, protein le
control. (B) Real-time PCR revealed an up-regulation of NRF-2α and βmRNA with NRF-2α/β
Grin2c, Grin2d, Grin3a, and Grin3bmRNA levels also increased with over-expression. As a po
each data point; ***=Pb0.001 and X=non-signiﬁcant when compared to control.3.10. Over-expression of NRF-2 rescued tetrodotoxin-induced transcript
reduction of Grin1 and Grin2b
Our lab has previously shown that 0.4 μM TTX decreases levels of
COX subunit transcript levels, as well as transcript levels of the Grin1
and Grin2b subunits of the NMDA receptors [7]. To determine if NRF-2
over-expression could rescue both COX subunit and Grin1 and Grin2b
subunit transcript levels, vectors expressing NRF-2 α and β subunits
were transfected into N2a cells that were later subjected to 0.4 μM
TTX treatment for 3 days. Control cells exposed to TTX showed a signif-
icant decrease of 35%, 21%, and 52% in transcript levels of the COX7c,
Grin1, and Grin2b subunits, respectively (Pb0.01, Pb0.05, and Pb0.001,
respectively; Fig. 6B). Cells that were transfected with NRF-2 α and β
over-expression vectors rescued the down-regulation seen with TTX
treatment, with an increase in COX7c, Grin1, and Grin2b of 132%, 143%,
and 167%, respectively, as compared to controls (Pb0.001 for all as com-
pared to TTX alone; Fig. 6B). As a negative control, transcript levels of
Grin2a and Grin3a decreased signiﬁcantly with TTX treatment (Fig. 6B)
and were not rescued by an over-expression of NRF-2α/β (Fig. 6B).
3.11. Homology of NRF-2 binding sites
The functional NRF-2 binding sites are conserved between mouse
and rat for Grin1, and among mouse, human, and rat for Grin2b
(Fig. 7).
4. Discussion
Using multiple approaches, including EMSA shift and supershift
assays, ChIP in both N2a and primary visual cortical neurons, and pro-
moter mutational analysis, the present study documents for the ﬁrstNMDA receptor subunit genes. (A)Western blots revealed an up-regulation of NRF-2α
vels increased signiﬁcantly with NRF-2α/β over-expression. β-actin served as a loading
over-expression as compared to control vectors. (C) Grin1 and Grin2b, but not Grin2a,
sitive control, COX7cmRNA levels increased with NRF-2α/β over-expression. N=6 for
Fig. 6. Effect of KCl or TTX treatment in the presence of NRF-2 silencing or over-expression,
respectively, on the transcript levels of Grin1, Grin2b, COX7c, Grin2a, and Grin3a. (A) N2a
cells treated for 5 h with 20 mM KCl revealed an up-regulation of all transcripts as com-
pared to controls. In the presence of shRNA against NRF-2α, 5 h treatment with 20 mM
KCl failed to up-regulate the transcripts of Grin1, Grin2b, and COX7c, but it did up-regulate
those of Grin2a and Grin3a. (B) N2a cells treated for 3 days with 0.4 μM TTX revealed a
down-regulation of all tested transcripts as compared to controls. Over-expression of
NRF-2α and β rescued the down-regulation of the COX7c, Grin1, and Grin2b transcripts,
but not those of Grin2a and Grin3a. N=6 for each data point; *=Pb0.05, **=Pb0.01,
and ***=Pb0.001 when compared to controls; ###=Pb0.001 and X=non-signiﬁcant
when compared to KCl- or TTX-treated samples.
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ceptor subunits GluN1 and GluN2B (Grin1 and Grin2b, respectively).
Silencing of NRF-2 resulted in a concurrent decrease in mRNA and
protein levels of Grin1 (GluN1), Grin2b (GluN2B), and COX7c, where-
as over-expression of NRF-2 resulted in a concurrent increase in these
transcript and protein levels. Furthermore, NRF-2 regulatory sites
tested in this study are conserved between mice and rats, and, in
the case of Grin2b, with humans.
In neurons, there exists an intimate link between NRF-2, energyme-
tabolism, and neuronal activity. NRF-2's pattern of distribution in the
monkey visual cortex is almost identical to that of COX [15,17,18], an
enzyme critical for energy production in neurons, under normal and
functionally deprived states. Such closeness in distribution pattern
with COX has not yet been seen with any other transcription factor. If
neuronal activity is blocked in adult macaque monkeys by monocular
injections of TTX, a toxin that inhibits voltage-dependent sodiumFig. 7. Aligned partial sequences of Grin1 and Grin2b promoters fromchannels, there is a parallel reduction in mRNA and protein levels of
both NRF-2 and COX in deprived visual cortical neurons. Increased or
blockade of neuronal activity causes a transcriptional up or down-
regulation, respectively, of both NRF-2 α and β subunits [16,24], with
increased neuronal activity also causing a nuclear translocation of
both subunits [14]. The link between NRF-2, energy metabolism, and
neuronal activity at the molecular level is revealed by our previous re-
port that NRF-2 regulates all 13 subunits of COX [19,21], and by the cur-
rent novel ﬁnding that NRF-2 regulates both GluN1 and GluN2B
subunits of the NMDA receptors.
GluN1 subunit is expressed in all neurons and is obligatory for the
formation of functional NMDA receptors. Most NMDA receptors are
composed of two GluN1 and two GluN2A or GluN2B subunits [2]. Of
the GluN2A and GluN2B subtypes, the GluN1/GluN2A receptor con-
fers a lower afﬁnity for glutamate and faster kinetics. It is widely
expressed in the adult brain. The GluN1/GluN2B subtype is present
in the neonatal and adult brain. It is associated with long-term poten-
tiation [25], a feature of learning and memory. GluN1/GluN2B recep-
tors have slower channel kinetics and lower open probability than
GluN1/GluN2A receptors. Once activated, GluN1/GluN2B receptors
allow for the entry of large amounts of cations, particularly Ca2+. The
entry of Ca2+ through GluN2B receptors, combined with the receptor's
direct interactions with downstream signaling proteins, is responsible
for learning andmemory [25,26] and, when in excess, excitatory neuro-
toxicity [27]. The proper function and regulation of the GluN2B gene are
critical to neuronal survival, and disruption of its expression in mice
causes perinatal lethality [28]. On the other hand, disruption of the
GluN2A gene allows for viability [28]. Thus, NRF-2 regulates two critical
subunits of NMDA receptors, GluN1 and GluN2B.
The present study found thatNRF-2 does not regulate the expression
of Grin2a, Grin2c-d, and Grin3a-b genes, and our previous study indi-
cates that NRF-1 does not regulate these subunits either [7]. GluN2D is
expressed prenatallywhile GluN2C is expressed in a distinct spatial pat-
tern in the adult. The GluN3A-B subunits have reduced surface expres-
sion in both the neonatal and adult brains [29,30]. Functional studies to
determine the identity of regulatory elements for these genes have not
yet been reported.
Neuronal activity is a highly energy intensive process, with themost
energy consuming step being the constant repolarization of the mem-
brane potential through active pumping out of cations that enter via ex-
citatory neurotransmitter receptors. GluN1/2B receptors play a critical
role in neuronal activity, neuronal plasticity, and the proper functioning
of neurons. The GluN2B subunit is required for the proper trafﬁcking of
NMDA receptors to the cell surface [31], and its direct interactions with
downstream signaling proteins are responsible for some of its effects
[26]. Furthermore, the critical role of GluN1/2B receptors in neuronal
development, plasticity, and functioning cannot be substituted or re-
placed by GluN1/2A [32]. Thus, GluN1/GluN2B containing receptors
are important regulators of neuronal activity, and NRF-2 plays a vital
role in this regulation and in coordinating synaptic transmission with
energy generation.
NRF-2 regulates the same NMDA receptor subunits as nuclear
respiratory factor 1 (NRF-1) [7], a transcription factor that also regulatesmouse, rat, and human showed conserved NRF-2 binding sites.
Fig. 8. Venn diagram depicting that NRF-2, NRF-1, and perhaps other transcription factors
mediate the tight coupling between neuronal activity (NMDA receptors) and energy
metabolism (cytochrome c oxidase) at the molecular level.
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neuronal activity. Howdo these two factors operate together tomediate
such co-regulation? Three mechanisms are possible: complementary,
concurrent and parallel, and a combination of complementary and
concurrent/parallel mechanisms. In the complementary mechanism,
NRF-2 regulates NMDA receptor subunit genes complementary to
those regulated byNRF-1,whereas in the concurrent and parallelmech-
anism, NRF-2 and NRF-1 jointly regulate the same subunit genes in a
parallel fashion (both are stimulatory). In a combination of the comple-
mentary and concurrent/parallelmechanisms, a subset of subunit genes
controlled byNRF-2 is also concurrently controlled by NRF-1. This study
documents that themechanism used to co-regulate energymetabolism
(COX) and neuronal activity (NMDA receptors) by NRF-2 and NRF-1 is
the concurrent and parallel mechanism (see Fig. 8). We have veriﬁed
in previous reports that silencing either NRF-1 or NRF-2 did not affect
the expression of the other [8,19]. Thus, NRF-2 and NRF-1 operate inde-
pendently of each other. A possible beneﬁt of the concurrent and paral-
lel mechanism is safety — ensuring that genes important for neuronal
functioning are dually regulated. This mitigates possible detrimental
effects of either failure or dysfunction of NRF-1 or NRF-2.
It is unlikely that the two transcription factors exist solely for re-
dundancy. Knockout of either transcription factor is embryonically le-
thal. Whereas NRF-2 and NRF-1 both co-regulate energy metabolism
and neuronal activity, and each is regulated by neuronal activity,
there may be subtle differences. NRF-2 has a virtually identical pat-
tern of distribution as COX in the macaque visual cortex [15,17,18],
whereas NRF-1 does not [unpublished observations]. It is possible
that NRF-1 is co-regulating neuronal activity and energy metabolism
at a basal level, while NRF-2 closely monitors changes in neuronal
activity, and therefore, in energy demand, to affect its target genes.
Distinct subtle differences in the roles of the two transcription factors
that may lead to the ﬁne tuning of Grin1 and Grin2b expression under
different neuronal activities or metabolic conditions, are important, as
the GluN1/2B receptor is critical for normal function but, when acti-
vated in excess, is responsible for excitotoxicity and neuronal death.
NRF-2 and NRF-1 mediate the tight coupling of neuronal activity
to energy metabolism, but it is possible that there are other transcrip-
tion factors that also mediate this coupling. Transcription factors such
as those in the speciﬁcity family and CREB, as well as transcription
coactivators, such as peroxisome proliferator-activated receptor-γ
coactivator 1α (PGC-1α), known to stimulate a powerful induction
of both NRF-1 and NRF-2 [33], may be involved in such regulation.
Research is underway to explore such possibilities.
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